NYSE · Financial Statements
GMED (GMED) Financial Statements
$80.48
NYSE: GMED
Market Cap $10.85B
Overview Financials Dividend GMED most recently reported annual revenue of $2.9B, net profit of $538.0M, revenue has compounded at 30.1% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $958.0M $1.0B $1.6B $2.5B $2.9B Operating Profit $172.0M $228.0M $133.0M $166.0M $480.0M Net Profit $149.0M $190.0M $123.0M $103.0M $538.0M EPS $1.44 $1.85 $1.07 $0.75 $3.92 Op Margin 17.9% 22.3% 8.5% 6.6% 16.3%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $2.0B $2.1B $5.1B $5.3B $5.3B Total Liabilities $216.0M $230.0M $1.1B $1.1B $730.0M Cash $193.0M $150.0M $467.0M $784.0M $526.0M Borrowings $0 $6.0M $520.0M $537.0M $119.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $276.0M $178.0M $243.0M $521.0M $753.0M Investing Cash Flow $-433.0M $-184.0M $225.0M $-291.0M $-520.0M Financing Cash Flow $54.0M $-110.0M $-232.0M $-28.0M $-679.0M Net Cash Flow $-46.0M $-43.0M $317.0M $317.0M $-258.0M Free Cash Flow $219.0M $104.0M $165.0M $405.0M $589.0M
Screens featuring this stock